Skip to content

IQVIA IQV Treasury stock, shares (in shares)

Treasury stock, shares (in shares) at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
Medpace Holdings, Inc. logo
Medpace Holdings, Inc.MEDP
Tempus AI, Inc. logo
Tempus AI, Inc.TEM

Other financials

Income statement

See full
Revenue$4.2B+8.4%
Gross profit$1.4B+4.4%
Operating income$514.0M+3.6%
Net income$274.0M+10.0%
EPS (diluted)$1.61+15.0%

Balance sheet

See full
Cash & equivalents$1.9B+11.9%
Total debt$16.1B+10.7%
Total equity$6.2B+4.1%
Total assets$29.7B+8.6%

Cash flow

See full
Operating cash flow$618.0M+8.8%
CapEx$127.0M-10.6%
Free cash flow$491.0M+15.3%

Valuation

See full
Market cap$32.25B+26.3%
Enterprise value$46.37B+18.6%
P/E23.3×+2.6×
P/S1.9×+0.3×

Profitability

See full
Gross margin33%-1.7pp
Operating margin13.2%-0.9pp
Net margin8.3%-0.3pp
FCF margin12.7%-1.2pp

Returns & leverage

See full
Return on equity22.7%+1.1pp
Debt / equity2.6×+0.2×
Current ratio0.7×-0.1×

Where this comes from

Reported directly by IQVIA in its filing.

Tagged under the XBRL concept us-gaap:TreasuryStockCommonShares.

The official record: IQVIA’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about IQVIA's treasury stock, shares (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is IQVIA's treasury stock, shares (in shares)?
IQVIA (IQV) reported treasury stock, shares (in shares) of $92.7M in Q1 2026.
How has IQVIA's treasury stock, shares (in shares) changed year-over-year?
IQVIA's treasury stock, shares (in shares) increased by 9.8% year-over-year, from $84.4M to $92.7M.
What is the long-term trend for IQVIA's treasury stock, shares (in shares)?
Over 5 years (2020 to 2025), IQVIA's treasury stock, shares (in shares) has grown at a 7.1% compound annual growth rate (CAGR), from $63.5M to $89.5M.